Skip to main content
Mehmet Orman

Mehmet Orman

Associate Professor

Dr. Mehmet A. Orman is an Associate Professor in the Department of Biomedical Engineering at the University of Wisconsin-Madison. He received his Ph.D. in Chemical and Biochemical Engineering from Rutgers University, where his doctoral research focused on systems-level and computational analyses of metabolic regulation in the liver under stress conditions, including burn injury and infection. Following his Ph.D., Dr. Orman completed postdoctoral training at Princeton University, where he studied the metabolic mechanisms underlying bacterial persistence and antibiotic tolerance, and at Memorial Sloan Kettering Cancer Center, where he investigated DNA repair pathways in cancer cells. He subsequently began his academic career in the Department of Chemical and Biomolecular Engineering at the University of Houston, where he established an externally funded research program and was promoted to Associate Professor, before transferring his laboratory to the University of Wisconsin-Madison, where his group continues to investigate drug-tolerant persister phenotypes across bacterial and cancer systems. Dr. Orman’s work has been supported by major federal awards, including an NSF CAREER Award, an NIH NIAID Career Transition Award (K22), and multiple NIH R01 grants. He has also been recognized for excellence in teaching at the Cullen College of Engineering at the University of Houston.

Dr. Orman’s research integrates quantitative experiments, single-cell approaches, and computational modeling to uncover the mechanisms driving drug tolerance, persistence, and recovery in both bacterial and cancer systems.

Department

Biomedical Engineering

Contact

Engineering Centers Building
1550 Engineering Dr
Madison, WI

Featured news

  • PhD 2011, Rutgers University
  • MS 2007, METU
  • BS 2005, METU

  • Molecular mechanisms underlying drug-tolerant persister phenotypes in bacteria and cancer cells
  • Metabolic rewiring, energy homeostasis, and stress-response pathways that support survival under antibiotic or chemotherapeutic pressure
  • Antibiotic tolerance, persistence, and the emergence of resistance, with emphasis on post-treatment recovery dynamics
  • DNA damage responses, repair pathways, and mutagenesis associated with survival following antimicrobial or anticancer therapies
  • Single-cell analysis of heterogeneous populations using quantitative microscopy, flow cytometry, and time-lapse imaging
  • Bacterial-mammalian cell interactions, including adhesion, motility, and tolerance in host-associated environments
  • High-throughput phenotypic and chemical screening strategies to identify metabolic vulnerabilities in persister cells
  • Systems biology, computational modeling, and machine-learning approaches to predict and classify drug-tolerant subpopulations

  • 2024 University of Houston, Cullen College of Engineering Teaching Excellence Award
  • 2022 Assistant Professor Excellence Lecture Series (APEX)
  • 2021 NSF, CAREER Award
  • 2019 NIAID/NIH, R01 Research Award
  • 2017 NIAID, Career Transition Award (K22)
  • 2007 METU, Academic Performance Award in M.S. program
  • 2007 Turkish Ministry of National Education, Ph.D. Scholarship to study abroad (Awarded; Declined by the Awardee)
  • 2005 M.S. Bursary of Scientific & Technical Research Council of Turkey (TÜBİTAK)

  • Singh, G., Mohiuddin, S. G., Ghosh, S., Narzary, J., Orman, M., & Nikolaou, M. (2025). Systematic design of pulse dosing to eradicate persister bacteria: The case of fluoroquinolones. Computers & Chemical Engineering, 195, 109010.
  • Grimsley, H. E., Courtemanche, K., Cox, S., McDermott, N., Sharma, A., Bright, J., Setton, J., Orman, M., & Powell, S. N. (2025). The 9-1-1 complex protects ssDNA gaps in BRCA2-deficient cancer. bioRxiv, 2025--10.
  • Mohiuddin, S. G., Kavousi, P., Figueroa, D., Ghosh, S., & Orman, M. (2025). The diverse phenotypic and mutational landscape induced by fluoroquinolone treatment. Msystems, 10(8), e00713-25.
  • Sensenbach, S., Ngo, H. G., Ghosh, S., Karki, P., Angardi, V., & Orman, M. (2025). The Role of c-Jun Signaling in Cytidine Analog-Induced Cell Death in Melanoma. ACS omega, 10(29), 31776-31788.
  • Ngo, H. G., Mohiuddin, S. G., Ananda, A., & Orman, M. (2025). Unraveling Crp/cAMP-mediated metabolic regulation in Escherichia coli persister cells. Elife, 13, RP99735.
  • Ghosh, S., Narzary, J., & Orman, M. (2025). UV-B-Induced DNA Repair Mechanisms and Their Effects on Mutagenesis and Culturability in Escherichia coli. bioRxiv, 2024-11.
  • Kumar, U. R., Nguyen, N. T., Dewangan, N. K., Mohiuddin, S. G., Orman, M., Cirino, P. C., & Conrad, J. C. (2024). Co-Expression of type 1 fimbriae and flagella in Escherichia coli: consequences for adhesion at interfaces. Soft Matter, 20(37), 7397-7404.
  • Ghosh, S., & Orman, M. (2024). Exploring the links between SOS response, mutagenesis, and resistance during the recovery period. Antimicrobial Agents and Chemotherapy, 68(5), e01462-23.
  • Zhu, Y., Pei, X., Novaj, A., Setton, J., Bronder, D., Derakhshan, F., Selenica, P., McDermott, N., Orman, M., Plum, S., & others, (2024). Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors. Genome Medicine, 16(1), 108.
  • Shiraliyev, R., & Orman, M. (2024). Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance. Elife, 13, RP94903.

  • BME 790 - Master's Research and Thesis (Spring 2026)
  • BME 799 - Advanced Independent Study (Spring 2026)
  • BME 890 - Pre-dissertation Research (Spring 2026)
  • BME 990 - Research and Thesis (Spring 2026)